Trials / Completed
CompletedNCT02915094
Kineret in the Treatment of Rheumatoid Arthritis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Swedish Orphan Biovitrum · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Objective of the study is to gain knowledge about the administration of Kineret in patients with rheumatoid arthritis in the daily routine treatment and not in controlled trials. In the current survey, the investigation of the response rate of Kineret regarding the date of onset of action, the efficacy, as well as the tolerability and safety are of particular interest.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anakinra |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2016-09-26
- Last updated
- 2017-08-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02915094. Inclusion in this directory is not an endorsement.